Selected research
Industry Research
Alfuzosin Industry Research Report 2026
Market perspective
The global Alfuzosin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Alfuzosin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Alfuzosin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Alfuzosin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Alfuzosin include Teva, Sun Pharma, Mylan, Wockhardt, Unichem Laboratories, Torrent Pharmaceuticals, Cipla, Aurobindo and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Alfuzosin market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Alfuzosin Market by Company
Teva
Sun Pharma
Mylan
Wockhardt
Unichem Laboratories
Torrent Pharmaceuticals
Cipla
Aurobindo
Apotex
Alfuzosin Segment by Type
2.5mg Tablets
10mg Tablets
Alfuzosin Segment by Application
Hospital
Drug store
Alfuzosin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alfuzosin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alfuzosin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alfuzosin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Alfuzosin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Alfuzosin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Alfuzosin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2.5mg Tablets
- 10mg Tablets
Applications
- Hospital
- Drug store
Companies covered
- Teva
- Sun Pharma
- Mylan
- Wockhardt
- Unichem Laboratories
- Torrent Pharmaceuticals
- Cipla
- Aurobindo
- Apotex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Alfuzosin Market Size (2021-2032)
- 2.2.2 Global Alfuzosin Sales (2021-2032)
- 2.2.3 Global Alfuzosin Market Average Price (2021-2032)
- 2.3 Alfuzosin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 2.5mg Tablets
- 2.3.3 10mg Tablets
- 2.4 Alfuzosin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Drug store
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Alfuzosin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Alfuzosin Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Alfuzosin Revenue of Manufacturers (2021-2026)
- 3.4 Global Alfuzosin Average Price by Manufacturers (2021-2026)
- 3.5 Global Alfuzosin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Alfuzosin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Alfuzosin, Product Type & Application
- 3.8 Global Manufacturers of Alfuzosin, Established Date
- 3.9 Global Alfuzosin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Alfuzosin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Alfuzosin Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Sun Pharma
- 4.2.1 Sun Pharma Company Information
- 4.2.2 Sun Pharma Business Overview
- 4.2.3 Sun Pharma Alfuzosin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharma Alfuzosin Product Portfolio
- 4.2.5 Sun Pharma Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Alfuzosin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Alfuzosin Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Wockhardt
- 4.4.1 Wockhardt Company Information
- 4.4.2 Wockhardt Business Overview
- 4.4.3 Wockhardt Alfuzosin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Wockhardt Alfuzosin Product Portfolio
- 4.4.5 Wockhardt Recent Developments
- 4.5 Unichem Laboratories
- 4.5.1 Unichem Laboratories Company Information
- 4.5.2 Unichem Laboratories Business Overview
- 4.5.3 Unichem Laboratories Alfuzosin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Unichem Laboratories Alfuzosin Product Portfolio
- 4.5.5 Unichem Laboratories Recent Developments
- 4.6 Torrent Pharmaceuticals
- 4.6.1 Torrent Pharmaceuticals Company Information
- 4.6.2 Torrent Pharmaceuticals Business Overview
- 4.6.3 Torrent Pharmaceuticals Alfuzosin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Torrent Pharmaceuticals Alfuzosin Product Portfolio
- 4.6.5 Torrent Pharmaceuticals Recent Developments
- 4.7 Cipla
- 4.7.1 Cipla Company Information
- 4.7.2 Cipla Business Overview
- 4.7.3 Cipla Alfuzosin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cipla Alfuzosin Product Portfolio
- 4.7.5 Cipla Recent Developments
- 4.8 Aurobindo
- 4.8.1 Aurobindo Company Information
- 4.8.2 Aurobindo Business Overview
- 4.8.3 Aurobindo Alfuzosin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Aurobindo Alfuzosin Product Portfolio
- 4.8.5 Aurobindo Recent Developments
- 4.9 Apotex
- 4.9.1 Apotex Company Information
- 4.9.2 Apotex Business Overview
- 4.9.3 Apotex Alfuzosin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Apotex Alfuzosin Product Portfolio
- 4.9.5 Apotex Recent Developments
5 Global Alfuzosin Market Scenario by Region
- 5.1 Global Alfuzosin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Alfuzosin Sales by Region: 2021-2032
- 5.2.1 Global Alfuzosin Sales by Region: 2021-2026
- 5.2.2 Global Alfuzosin Sales by Region: 2027-2032
- 5.3 Global Alfuzosin Revenue by Region: 2021-2032
- 5.3.1 Global Alfuzosin Revenue by Region: 2021-2026
- 5.3.2 Global Alfuzosin Revenue by Region: 2027-2032
- 5.4 North America Alfuzosin Market Facts & Figures by Country
- 5.4.1 North America Alfuzosin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Alfuzosin Sales by Country (2021-2032)
- 5.4.3 North America Alfuzosin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Alfuzosin Market Facts & Figures by Country
- 5.5.1 Europe Alfuzosin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Alfuzosin Sales by Country (2021-2032)
- 5.5.3 Europe Alfuzosin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Alfuzosin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Alfuzosin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Alfuzosin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Alfuzosin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Alfuzosin Market Facts & Figures by Country
- 5.7.1 South America Alfuzosin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Alfuzosin Sales by Country (2021-2032)
- 5.7.3 South America Alfuzosin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Alfuzosin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Alfuzosin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Alfuzosin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Alfuzosin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Alfuzosin Sales by Type (2021-2032)
- 6.1.1 Global Alfuzosin Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Alfuzosin Sales Market Share by Type (2021-2032)
- 6.2 Global Alfuzosin Revenue by Type (2021-2032)
- 6.2.1 Global Alfuzosin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Alfuzosin Revenue Market Share by Type (2021-2032)
- 6.3 Global Alfuzosin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Alfuzosin Sales by Application (2021-2032)
- 7.1.1 Global Alfuzosin Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Alfuzosin Sales Market Share by Application (2021-2032)
- 7.2 Global Alfuzosin Revenue by Application (2021-2032)
- 7.2.1 Global Alfuzosin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Alfuzosin Revenue Market Share by Application (2021-2032)
- 7.3 Global Alfuzosin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Alfuzosin Value Chain Analysis
- 8.1.1 Alfuzosin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Alfuzosin Production Mode & Process
- 8.2 Alfuzosin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Alfuzosin Distributors
- 8.2.3 Alfuzosin Customers
9 Global Alfuzosin Analyzing Market Dynamics
- 9.1 Alfuzosin Industry Trends
- 9.2 Alfuzosin Industry Drivers
- 9.3 Alfuzosin Industry Opportunities and Challenges
- 9.4 Alfuzosin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst